Hematological Malignancies
Showing NaN - NaN of 6
Hematological Malignancies Trial in Worldwide (Pembrolizumab/vibostolimab coformuation)
Recruiting
- Hematological Malignancies
- Pembrolizumab/vibostolimab coformuation
-
Duarte, California
- +64 more
Jan 27, 2023
Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®
Active, not recruiting
- Hematological Malignancies
- +6 more
- NiCord® (omidubicel)
- Cord Blood Unit
-
Los Angeles, California
- +51 more
Jan 7, 2021
Hematological Malignancies Trial in Haifa, Jerusalem (Allogeneic MPBC transplantation from matched related donor)
Unknown status
- Hematological Malignancies
- Allogeneic MPBC transplantation from matched related donor
-
Haifa, Israel
- +1 more
Nov 24, 2019
GVHD, Hematological Malignancies Trial in Jerusalem (ApoCell)
Unknown status
- Graft Versus Host Disease
- Hematological Malignancies
- ApoCell
-
Jerusalem, IsraelDepartment of Bone Marrow Transplantation
Jun 10, 2015
Hematological Malignancies Trial in Worldwide (HSV-TK)
Completed
- Hematological Malignancies
- HSV-TK
-
Hannover, Germany
- +7 more
May 29, 2014